Dr. MacKinnon is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
619 19th St S
Birmingham, AL 35249Phone+1 205-934-4011Fax+1 205-297-9411
Education & Training
- University of ChicagoFellowship, Molecular Genetic Pathology, 2008 - 2009
- University of ChicagoResidency, Pathology-Anatomic and Clinical, 2004 - 2007
- University of Illinois College of MedicineClass of 2004
Certifications & Licensure
- AL State Medical License 2019 - 2024
- WI State Medical License 2010 - 2023
- IL State Medical License 2004 - 2014
- American Board of Pathology Pathology - Anatomic
- American Board of Pathology Pathology - Molecular Genetic
Publications & Presentations
PubMed
- 47 citationsProstate cancer risk locus at 8q24 as a regulatory hub by physical interactions with multiple genomic loci across the genomeMeijun Du, Tiezheng Yuan, Kala F. Schilter, Rachel L. Dittmar, Alexander C. Mackinnon
Human Molecular Genetics. 2015-01-01 - 35 citationsMolecular biology underlying the clinical heterogeneity of prostate cancer: an update.A. Craig Mackinnon, Benjamin C. Yan, Loren Joseph, Hikmat Al-Ahmadie
Archives of Pathology & Laboratory Medicine. 2009-10-21 - 22 citationsThe SmgGDS Splice Variant SmgGDS-558 Is a Key Promoter of Tumor Growth and RhoA Signaling in Breast CancerAndrew D. Hauser, Carmen Bergom, Nathan J. Schuld, Xiuxu Chen, Ellen L. Lorimer
Molecular Cancer Research. 2014-01-01
Journal Articles
- Original Contribution MDM2 Amplification and Immunohistochemical Expression in Sarcomatoid Renal Cell CarcinomaSaul Suster, Alexander C Mackinnon, Shira Ronen, ScienceDirect
- Expression of PD-L1/PD-1 in Lymphoepithelioma-like Carcinoma of the ThymusDavid Suster, Saul Suster, Alexander C Mackinnon, German Pihan, Nature
Press Mentions
- Biocartis Group NV: Biocartis Launches Innovative Idylla(TM) MSI AssayJuly 17th, 2018
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: